DRI Healthcare Trust Cash Flow Conversion Efficiency
DRI Healthcare Trust cash flow conversion efficiency. Based on the latest financial reports, DRI Healthcare Trust (DHT-U) has a cash flow conversion efficiency ratio of 0.053x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($26.92 Million) by net assets ($503.60 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of DRI Healthcare Trust (2020–2024)
Cash flow conversion efficiency of DRI Healthcare Trust from 2020 to 2024. This chart illustrates how DRI Healthcare Trust's cash flow conversion efficiency has evolved over time, based on yearly financial data. View DHT-U live share price for real-time trading data and today's change.
DRI Healthcare Trust Cash Flow Conversion Ratio Explained
DRI Healthcare Trust cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
DRI Healthcare Trust Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DRI Healthcare Trust ranked by their cash flow conversion efficiency. Also see DHT-U market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Guangju Energy Co Ltd
SHE:000096
|
0.003x |
|
Rezolve AI Limited Ordinary Shares
NASDAQ:RZLV
|
-0.229x |
|
Sundiro Holding Co Ltd
SHE:000571
|
-0.031x |
|
Complete Logistic Services Bhd
KLSE:5136
|
0.029x |
|
Zhejiang Tianzhen Technology Co. Ltd. A
SHE:301356
|
N/A |
|
Sichuan Mingxing Electric Power Co Ltd
SHG:600101
|
0.044x |
|
Zhejiang Talent Television&Film Co Ltd
SHE:300426
|
-0.598x |
|
BRASKEM PFD ADR/2 O.N.
F:BRD
|
0.055x |
Annual Cash Flow Conversion Efficiency for DRI Healthcare Trust (2020–2024)
The table below shows the annual cash flow conversion efficiency of DRI Healthcare Trust from 2020 to 2024. Review DHT-U cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $527.53 Million | $155.41 Million | 0.295x | +114.05% |
| 2023-12-31 | $561.50 Million | $77.28 Million | 0.138x | -33.85% |
| 2022-12-31 | $372.34 Million | $77.47 Million | 0.208x | -14.17% |
| 2021-12-31 | $378.99 Million | $91.86 Million | 0.242x | +100.00% |
| 2020-12-31 | $-352.00 | $91.86 Million | -260977.273x | -- |
About DRI Healthcare Trust
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.